1-2 of 2
Noboru Yamamoto
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A First-in-Human Phase I Study of CTX-712 in Patients with Advanced, Relapsed or Refractory Malignant Tumors - Hematologic Malignancies Dose Escalation Cohort

Hisayuki Yokoyama, Koji Ando, Noriko Fukuhara, Hiroatsu Iida, Suguru Fukuhara, Hiroshi Miyake, Yasushi Tanoue, Maki Yamamoto, Hirokazu Tozaki, Akio Mizutani, Daisuke Morishita, Kunihiko Takeyama, Toshio Shimizu, Noboru Yamamoto
Journal: Blood
Blood (2022) 140 (Supplement 1): 6211–6212.
https://doi.org/10.1182/blood-2022-157241
Published: 2022
Journal Articles

Cytokine Release Syndrome and Tumor Responses in a First-in-Man Trial of a Novel Affinity-Enhanced TCR-Gene Transduced T Cell Transfer Targeting NY-ESO-1 Antigen

Shinichi Kageyama, Mikiya Ishihara, Shigehisa Kitano, Yoshihiro Miyahara, Hidefumi Kato, Hideyuki Mishima, Noboru Yamamoto, Hiroyoshi Hattori, Hiroaki Iwase, Takeru Funakoshi, Takashi Kojima, Naoki Inoue, Tomohide Kidokoro, Daisuke Tomura, Sachiko Okamoto, Hideto Chono, Ikuei Nukaya, Junichi Mineno, Hiroaki Ikeda, Takashi Watanabe, MDPhD, Hiroshi Shiku
Journal: Blood
Blood (2017) 130 (Supplement 1): 841.
https://doi.org/10.1182/blood.V130.Suppl_1.841.841
Published: 2017